세계의 돈단독 에리시펠라스 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Swine Erysipelas Vaccine Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02194 입니다.■ 상품코드 : LPI-2201K02194
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 103
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,941,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,411,500견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩9,882,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 돈단독 에리시펠라스 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (라이브, 비활성화)와 용도별 시장규모 (약국, 온라인 판매, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 돈단독 에리시펠라스 백신 시장 점유율
- 지역별 돈단독 에리시펠라스 백신 시장규모
- 주요지역의 종류별 시장규모 (라이브, 비활성화)
- 주요지역의 용도별 시장규모 (약국, 온라인 판매, 기타)
- 미주의 돈단독 에리시펠라스 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 돈단독 에리시펠라스 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 돈단독 에리시펠라스 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 돈단독 에리시펠라스 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 돈단독 에리시펠라스 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Zoetis, Merck, Boehringer Ingelheim, Qilu Animal Health, CAHIC, Chengdu Tianbang Biology, Jiujiang Bomeilai Biological, Jilin Zhengye Biological, Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Swine Erysipelas Vaccine will have significant change from previous year. By the most conservative estimates of global Swine Erysipelas Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Swine Erysipelas Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Swine Erysipelas Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Live
Inactivated

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pharmacy
Online Sale
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
Merck
Boehringer Ingelheim
Qilu Animal Health
CAHIC
Chengdu Tianbang Biology
Jiujiang Bomeilai Biological
Jilin Zhengye Biological
Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
Hunan Zhong’an Biological Pharmaceutical Co., Ltd.

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Erysipelas Vaccine Consumption 2016-2026
2.1.2 Swine Erysipelas Vaccine Consumption CAGR by Region
2.2 Swine Erysipelas Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Swine Erysipelas Vaccine Sales by Type
2.3.1 Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Swine Erysipelas Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Swine Erysipelas Vaccine Sale Price by Type (2016-2021)
2.4 Swine Erysipelas Vaccine Segment by Distribution Channel
2.4.1 Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Swine Erysipelas Vaccine Sales by Distribution Channel
2.5.1 Global Swine Erysipelas Vaccine Sale Market Share by Distribution Channel (2016-2021)
2.5.2 Global Swine Erysipelas Vaccine Revenue and Market Share by Distribution Channel (2016-2021)
2.5.3 Global Swine Erysipelas Vaccine Sale Price by Distribution Channel (2016-2021)

3 Global Swine Erysipelas Vaccine by Company
3.1 Global Swine Erysipelas Vaccine Sales Market Share by Company
3.1.1 Global Swine Erysipelas Vaccine Sales by Company (2019-2021)
3.1.2 Global Swine Erysipelas Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Swine Erysipelas Vaccine Revenue Market Share by Company
3.2.1 Global Swine Erysipelas Vaccine Revenue by Company (2019-2021)
3.2.2 Global Swine Erysipelas Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Swine Erysipelas Vaccine Sale Price by Company
3.4 Global Manufacturers Swine Erysipelas Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Erysipelas Vaccine Product Location Distribution
3.4.2 Players Swine Erysipelas Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Swine Erysipelas Vaccine by Region
4.1 Global Swine Erysipelas Vaccine by Region
4.1.1 Global Swine Erysipelas Vaccine Sales by Region
4.1.2 Global Swine Erysipelas Vaccine Revenue by Region
4.2 Americas Swine Erysipelas Vaccine Sales Growth
4.3 APAC Swine Erysipelas Vaccine Sales Growth
4.4 Europe Swine Erysipelas Vaccine Sales Growth
4.5 Middle East & Africa Swine Erysipelas Vaccine Sales Growth

5 Americas
5.1 Americas Swine Erysipelas Vaccine Sales by Country
5.1.1 Americas Swine Erysipelas Vaccine Sales by Country (2016-2021)
5.1.2 Americas Swine Erysipelas Vaccine Revenue by Country (2016-2021)
5.2 Americas Swine Erysipelas Vaccine Sales by Type
5.3 Americas Swine Erysipelas Vaccine Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Swine Erysipelas Vaccine Sales by Region
6.1.1 APAC Swine Erysipelas Vaccine Sales by Region (2016-2021)
6.1.2 APAC Swine Erysipelas Vaccine Revenue by Region (2016-2021)
6.2 APAC Swine Erysipelas Vaccine Sales by Type
6.3 APAC Swine Erysipelas Vaccine Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Swine Erysipelas Vaccine by Country
7.1.1 Europe Swine Erysipelas Vaccine Sales by Country (2016-2021)
7.1.2 Europe Swine Erysipelas Vaccine Revenue by Country (2016-2021)
7.2 Europe Swine Erysipelas Vaccine Sales by Type
7.3 Europe Swine Erysipelas Vaccine Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Swine Erysipelas Vaccine by Country
8.1.1 Middle East & Africa Swine Erysipelas Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Swine Erysipelas Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Swine Erysipelas Vaccine Sales by Type
8.3 Middle East & Africa Swine Erysipelas Vaccine Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Swine Erysipelas Vaccine Distributors
10.3 Swine Erysipelas Vaccine Customer

11 Global Swine Erysipelas Vaccine Market Forecast
11.1 Global Swine Erysipelas Vaccine Forecast by Region
11.1.1 Global Swine Erysipelas Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Swine Erysipelas Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Swine Erysipelas Vaccine Forecast by Type
11.7 Global Swine Erysipelas Vaccine Forecast by Distribution Channel

12 Key Players Analysis
12.1 Zoetis
12.1.1 Zoetis Company Information
12.1.2 Zoetis Swine Erysipelas Vaccine Product Offered
12.1.3 Zoetis Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zoetis Main Business Overview
12.1.5 Zoetis Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Swine Erysipelas Vaccine Product Offered
12.2.3 Merck Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Information
12.3.2 Boehringer Ingelheim Swine Erysipelas Vaccine Product Offered
12.3.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Boehringer Ingelheim Main Business Overview
12.3.5 Boehringer Ingelheim Latest Developments
12.4 Qilu Animal Health
12.4.1 Qilu Animal Health Company Information
12.4.2 Qilu Animal Health Swine Erysipelas Vaccine Product Offered
12.4.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Qilu Animal Health Main Business Overview
12.4.5 Qilu Animal Health Latest Developments
12.5 CAHIC
12.5.1 CAHIC Company Information
12.5.2 CAHIC Swine Erysipelas Vaccine Product Offered
12.5.3 CAHIC Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CAHIC Main Business Overview
12.5.5 CAHIC Latest Developments
12.6 Chengdu Tianbang Biology
12.6.1 Chengdu Tianbang Biology Company Information
12.6.2 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Offered
12.6.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Chengdu Tianbang Biology Main Business Overview
12.6.5 Chengdu Tianbang Biology Latest Developments
12.7 Jiujiang Bomeilai Biological
12.7.1 Jiujiang Bomeilai Biological Company Information
12.7.2 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Offered
12.7.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Jiujiang Bomeilai Biological Main Business Overview
12.7.5 Jiujiang Bomeilai Biological Latest Developments
12.8 Jilin Zhengye Biological
12.8.1 Jilin Zhengye Biological Company Information
12.8.2 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Offered
12.8.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Jilin Zhengye Biological Main Business Overview
12.8.5 Jilin Zhengye Biological Latest Developments
12.9 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
12.9.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
12.9.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Offered
12.9.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Main Business Overview
12.9.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Latest Developments
12.10 Hunan Zhong’an Biological Pharmaceutical Co., Ltd.
12.10.1 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Company Information
12.10.2 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Offered
12.10.3 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Main Business Overview
12.10.5 Hunan Zhong’an Biological Pharmaceutical Co., Ltd. Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Swine Erysipelas Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Live
Table 3. Major Players of Inactivated
Table 4. Global Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 5. Global Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Swine Erysipelas Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Swine Erysipelas Vaccine Sale Price by Type (2016-2021)
Table 9. Global Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 10. Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 11. Global Swine Erysipelas Vaccine Value by Distribution Channel (2016-2021)
Table 12. Global Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel (2016-2021)
Table 13. Global Swine Erysipelas Vaccine Sale Price by Distribution Channel (2016-2021)
Table 14. Global Swine Erysipelas Vaccine Sales by Company (2019-2021) & (K Units)
Table 15. Global Swine Erysipelas Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Swine Erysipelas Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Swine Erysipelas Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Swine Erysipelas Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Swine Erysipelas Vaccine Producing Area Distribution and Sales Area
Table 20. Players Swine Erysipelas Vaccine Products Offered
Table 21. Swine Erysipelas Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Swine Erysipelas Vaccine Sales by Region (2016-2021) (K Units)
Table 25. Global Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Swine Erysipelas Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 29. Americas Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Swine Erysipelas Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 33. Americas Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 35. Americas Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 36. APAC Swine Erysipelas Vaccine Sales by Region (2016-2021) & (K Units)
Table 37. APAC Swine Erysipelas Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Swine Erysipelas Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Swine Erysipelas Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 41. APAC Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 43. APAC Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 44. Europe Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 45. Europe Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Swine Erysipelas Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 49. Europe Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 51. Europe Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 52. Middle East & Africa Swine Erysipelas Vaccine Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Swine Erysipelas Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Swine Erysipelas Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Swine Erysipelas Vaccine Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Swine Erysipelas Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 59. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Table 60. Key and Potential Regions of Swine Erysipelas Vaccine
Table 61. Key Application and Potential Industries of Swine Erysipelas Vaccine
Table 62. Key Challenges of Swine Erysipelas Vaccine
Table 63. Key Trends of Swine Erysipelas Vaccine
Table 64. Swine Erysipelas Vaccine Distributors List
Table 65. Swine Erysipelas Vaccine Customer List
Table 66. Global Swine Erysipelas Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Swine Erysipelas Vaccine Consumption Market Forecast by Region
Table 68. Global Swine Erysipelas Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Swine Erysipelas Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Swine Erysipelas Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Swine Erysipelas Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Swine Erysipelas Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Swine Erysipelas Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Swine Erysipelas Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Swine Erysipelas Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Swine Erysipelas Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Swine Erysipelas Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Swine Erysipelas Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Swine Erysipelas Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Swine Erysipelas Vaccine Sales Forecast by Distribution Channel (2021-2026) & (K Units)
Table 83. Global Swine Erysipelas Vaccine Sales Market Share Forecast by Distribution Channel (2021-2026)
Table 84. Global Swine Erysipelas Vaccine Revenue Forecast by Distribution Channel (2021-2026) & ($ Millions)
Table 85. Global Swine Erysipelas Vaccine Revenue Market Share Forecast by Distribution Channel (2021-2026)
Table 86. Zoetis Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Zoetis Swine Erysipelas Vaccine Product Offered
Table 88. Zoetis Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Zoetis Main Business
Table 90. Zoetis Latest Developments
Table 91. Merck Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Swine Erysipelas Vaccine Product Offered
Table 93. Merck Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. Boehringer Ingelheim Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. Boehringer Ingelheim Swine Erysipelas Vaccine Product Offered
Table 98. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. Boehringer Ingelheim Main Business
Table 100. Boehringer Ingelheim Latest Developments
Table 101. Qilu Animal Health Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Qilu Animal Health Swine Erysipelas Vaccine Product Offered
Table 103. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Qilu Animal Health Main Business
Table 105. Qilu Animal Health Latest Developments
Table 106. CAHIC Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. CAHIC Swine Erysipelas Vaccine Product Offered
Table 108. CAHIC Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. CAHIC Main Business
Table 110. CAHIC Latest Developments
Table 111. Chengdu Tianbang Biology Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Offered
Table 113. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Chengdu Tianbang Biology Main Business
Table 115. Chengdu Tianbang Biology Latest Developments
Table 116. Jiujiang Bomeilai Biological Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Offered
Table 118. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. Jiujiang Bomeilai Biological Main Business
Table 120. Jiujiang Bomeilai Biological Latest Developments
Table 121. Jilin Zhengye Biological Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. Jilin Zhengye Biological Swine Erysipelas Vaccine Product Offered
Table 123. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Jilin Zhengye Biological Main Business
Table 125. Jilin Zhengye Biological Latest Developments
Table 126. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Offered
Table 128. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Main Business
Table 130. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Latest Developments
Table 131. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Basic Information, Swine Erysipelas Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Offered
Table 133. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Main Business
Table 135. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Swine Erysipelas Vaccine
Figure 2. Swine Erysipelas Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Erysipelas Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Swine Erysipelas Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Swine Erysipelas Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Swine Erysipelas Vaccine Sales Market Share by Type in 2020
Figure 12. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Swine Erysipelas Vaccine Consumed in Pharmacy
Figure 14. Global Swine Erysipelas Vaccine Market: Pharmacy (2016-2021) & (K Units)
Figure 15. Swine Erysipelas Vaccine Consumed in Online Sale
Figure 16. Global Swine Erysipelas Vaccine Market: Online Sale (2016-2021) & (K Units)
Figure 17. Swine Erysipelas Vaccine Consumed in Others
Figure 18. Global Swine Erysipelas Vaccine Market: Others (2016-2021) & (K Units)
Figure 19. Global Swine Erysipelas Vaccine Sales Market Share by Distribution Channel (2016-2021)
Figure 20. Global Swine Erysipelas Vaccine Revenue Market Share by Distribution Channel in 2020
Figure 21. Swine Erysipelas Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Swine Erysipelas Vaccine Revenue Market Share by Company in 2020
Figure 23. Global Swine Erysipelas Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global Swine Erysipelas Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas Swine Erysipelas Vaccine Sales 2016-2021 (K Units)
Figure 26. Americas Swine Erysipelas Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Swine Erysipelas Vaccine Sales 2016-2021 (K Units)
Figure 28. APAC Swine Erysipelas Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Swine Erysipelas Vaccine Sales 2016-2021 (K Units)
Figure 30. Europe Swine Erysipelas Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Swine Erysipelas Vaccine Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Swine Erysipelas Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Swine Erysipelas Vaccine Sales Market Share by Country in 2020
Figure 34. Americas Swine Erysipelas Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas Swine Erysipelas Vaccine Sales Market Share by Type in 2020
Figure 36. Americas Swine Erysipelas Vaccine Sales Market Share by Distribution Channel in 2020
Figure 37. United States Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Swine Erysipelas Vaccine Sales Market Share by Region in 2020
Figure 42. APAC Swine Erysipelas Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC Swine Erysipelas Vaccine Sales Market Share by Type in 2020
Figure 44. APAC Swine Erysipelas Vaccine Sales Market Share by Distribution Channel in 2020
Figure 45. China Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Swine Erysipelas Vaccine Sales Market Share by Country in 2020
Figure 52. Europe Swine Erysipelas Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe Swine Erysipelas Vaccine Sales Market Share by Type in 2020
Figure 54. Europe Swine Erysipelas Vaccine Sales Market Share by Distribution Channel in 2020
Figure 55. Germany Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Swine Erysipelas Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Swine Erysipelas Vaccine Sales Market Share by Distribution Channel in 2020
Figure 64. Egypt Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Swine Erysipelas Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
※본 조사보고서 [세계의 돈단독 에리시펠라스 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02194) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 돈단독 에리시펠라스 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!